Marizomib Completed Phase 1 Trials for Advanced Malignant Neoplasm Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00629473Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies